ClinicalTrials.gg
CompletedNCT06542328Updated Aug 7, 2024

Pre-market Verification of Portable X Ray Machines for Lung Diseases and Orthopedic Limb Lesions

An observational study in X-rays; Effects, Chest--Diseases and Orthopedic Disorder, sponsored by Energy Resources International Co., Ltd.. Completed at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2024-08-07.

Sponsored by Energy Resources International Co., Ltd. · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
228
Ages
20 Years and older
Sex
All
01

Study summary

The clinical trial is to evaluate a portable X ray machine (model name: CVXair) for chest and extremities diagnosis, the performance of machine is comparing to the commercial stationary and portable machine both in biological structure way and disease diagnosis way by the image generated.

Currently sold X ray machines in market for hospital are stationary or big size portable, it is not easy for carrying to use and occupied a large space for installation and storage, beside that, CVXair is a small and light machine within 3.2KG and has extremely low dosage. It is the reason we expect to use CVXair as a convenient X ray machine with low radiation dosage for X ray image diagnosis clinically.

This trial has an expected trial period in two years, the accepted patients are limited to thoracic and orthopedics patients no matter out hospital or in hospital. The accepted patients upper limitation number is 123 respectively. The selected patient will be taken X ray shot in same area and position both by CVXair and market sold machine, the images then will be interpreted by 2 qualified radiologist in different biological structure and specified diseases. Then the process will be given by a suitable test score.

The test result will be calculated by defined index for comparing with the market sold X ray machines, and finally we will base on the result to state the machine is equivalent or not by the market sold X ray machines.

02

Conditions studied

  • X-rays; Effects
  • Chest--Diseases
  • Orthopedic Disorder

Keywords

  • Portable X ray machine
  • Extremities
  • Telemedicie
03

In context

Musculoskeletal Diseases

668 studies on the registry are indexed under Musculoskeletal Diseases; 161 are open to participants now.

This study's enrollment of 228 is above the median of 132 across 208 observational studies indexed under Musculoskeletal Diseases.

Browse Musculoskeletal Diseases studies →

Lead sponsor

This is the only study on the registry with Energy Resources International Co., Ltd. as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult subjects suspected of having pulmonary diseases or orthopedic limb disorders.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with lung diseases and orthopedic limb lesions.
  • Aged 20 years or older.
  • After informed consent, sign the subject consent form.

Exclusion criteria

Exclusion Criteria:

  • Patients under the age of 20 years.
  • Pregnant women (female subjects of childbearing potential, undergo pregnancy testing prior to irradiation to exclude the risk of pregnancy).
  • Other individuals deemed unsuitable for inclusion in the clinical trial upon physician assessment.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
228 participants (actual)
Patient registry
No

Groups and cohorts

  • Pulmonology

    Device: ERI CVX-air portable X-ray system · Device: Samsung GM85 (K180543) or MobileDaRt Evolution (K080701)

  • Orthopaedic

    Device: ERI CVX-air portable X-ray system · Device: Samsung GC85A (K160997) or Fujifilm FDR Smart X (K212956)

Interventions

  • DeviceERI CVX-air portable X-ray system

    investigational device

  • DeviceSamsung GM85 (K180543) or MobileDaRt Evolution (K080701)

    The commercially available comparator equipment used for pulmonology.

  • DeviceSamsung GC85A (K160997) or Fujifilm FDR Smart X (K212956)

    The commercially available comparator equipment used for Orthopaedic.

06

What researchers measure

Primary outcomes

  1. Comparing the investigational device with the control device using Two Parellel-Sample Mean Test for Non-inferiority, the average scores of image quality at 5 anatomical sites.

    The average scores (Likert scale,1-4) for image quality at 5 anatomical sites/items generated by the investigational equipment for producing radiographic images of the thorax and limbs in human anatomy, compared to the commercial equipment, were evaluated based on the criteria defined in the study by Cheng Ting Lin et al. (Lin et al., 2020). These scores were assessed for diagnostic utility and level of defects.

    Time frame: Only images captured with the trial device and control device within a range of -1 day, 0 day, and 1 day from each other were selected for analysis.

07

Study locations

1 site
  • Changhua Christian Hospital
    Changhua, Changhua County 500, Taiwan
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2021 to primary completion in Jun 2022, 14 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 31, 2024
First posted
Aug 7, 2024
StartActual
Apr 1, 2021
Primary completionActual
Jun 23, 2022
CompletionActual
Aug 31, 2022
Last update
Aug 7, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 7, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06542328
Lead sponsor
Energy Resources International Co., Ltd.
Responsible party
Sponsor
First posted
Aug 7, 2024
Start date
Apr 1, 2021
Primary completion
Jun 23, 2022
Completion
Aug 31, 2022
Last update
Aug 7, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion